Literature DB >> 29131132

Points of Concern in Post Acute Kidney Injury Management.

Jill Vanmassenhove, Raymond Vanholder, Norbert Lameire.   

Abstract

The incidence of acute kidney injury (AKI) will in the future remain high, partly due to an increase in comorbidities and other AKI favoring factors such as the rise in high-risk diagnostic and therapeutic interventions. AKI has emerged as a major public health concern with high human and financial costs. It has recently been demonstrated that patients surviving an AKI episode show increased all-cause mortality, chronic kidney disease (CKD), ESRD, cardiovascular events, and reduced quality of life. Although it is important to acknowledge that, after an AKI episode, the risk of dying by far exceeds the risk of developing incident or progressive CKD and/or entering a maintenance renal replacement therapy (RRT) program, currently only a minority of patients are referred for renal follow-up, even after AKI-requiring RRT. On the other hand, renal follow-up for all AKI survivors might not be necessary and would represent an overwhelming work load for the health care system. There are at present no clear guidelines on which patients should be referred and on the elements of post AKI care that may improve non-renal and renal outcomes. In this review, we discuss several points of concern in post-AKI management and propose an algorithm on post-AKI care, mainly based on the renal recovery pattern at discharge from the hospital. Potential opportunities to improve care include appropriate risk stratification, close monitoring of kidney function, management of CKD complications, blood pressure control, medication reconciliation, and education of patients and non-nephrologists on AKI and its downstream complications.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Acute kidney injury; Chronic kidney disease; Outcome; Post acute kidney injury care; Quality improvement; Referral; Renal recovery

Mesh:

Year:  2017        PMID: 29131132     DOI: 10.1159/000484146

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  6 in total

1.  Long-term outcomes in acute kidney injury patients who underwent continuous renal replacement therapy: a single-center experience.

Authors:  Harin Rhee; Gum Sook Jang; Yeo Jin An; Miyeun Han; Inseong Park; Il Young Kim; Eun Young Seong; Dong Won Lee; Soo Bong Lee; Ihm Soo Kwak; Sang Heon Song
Journal:  Clin Exp Nephrol       Date:  2018-06-11       Impact factor: 2.801

2.  Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI.

Authors:  Chi-Yuan Hsu; Kathleen D Liu; Jingrong Yang; David V Glidden; Thida C Tan; Leonid Pravoverov; Sijie Zheng; Alan S Go
Journal:  Clin J Am Soc Nephrol       Date:  2019-12-16       Impact factor: 8.237

3.  Comparison of Static and Dynamic Baseline Creatinine Surrogates for Defining Acute Kidney Injury.

Authors:  David G Warnock; Javier A Neyra; Etienne Macedo; Ayme D Miles; Ravindra L Mehta; Christoph Wanner
Journal:  Nephron       Date:  2021-08-20       Impact factor: 3.457

Review 4.  Recovery after Critical Illness and Acute Kidney Injury.

Authors:  Anitha Vijayan; Emaad M Abdel-Rahman; Kathleen D Liu; Stuart L Goldstein; Anupam Agarwal; Mark D Okusa; Jorge Cerda
Journal:  Clin J Am Soc Nephrol       Date:  2021-08-30       Impact factor: 10.614

Review 5.  Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).

Authors:  Raymond Vanholder; Steven Van Laecke; Griet Glorieux; Francis Verbeke; Esmeralda Castillo-Rodriguez; Alberto Ortiz
Journal:  Toxins (Basel)       Date:  2018-06-12       Impact factor: 4.546

6.  Role of Urinary Beta 2 Microglobulin and Kidney Injury Molecule-1 in Predicting Kidney Function at One Year Following Acute Kidney Injury.

Authors:  Dhanin Puthiyottil; P S Priyamvada; Mattewada Naveen Kumar; Anand Chellappan; Bobby Zachariah; Sreejith Parameswaran
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-07-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.